Publications

5600 Results

Associations of Physical Activity with Survival and Progression in Metastatic Colorectal Cancer: Results from CALGB(Alliance)/SWOG 80405

Authors
B Guercio;S Zhang;F-S Ou;A Venook;D Niedzwiecki;H-J Lenz;F Innocenti;B O'Neil;JE Shaw;B Polite;H Hochster;J Atkins;R Goldberg;K Sato;K Ng;E Van Blarigan;RJ Mayer;CD Blanke;E O'Reilly;C Fuchs;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology Oct 10;37(29):2620-2631
Year
2019
Research Committee(s)
Gastrointestinal
PMID
PMID31408415
PMC
PMC6900834
Study Number(s)
CTSU/C80405

5a-Reductase Inhibitor Use in Patients With Prostate Cancer [Letter to the Editor/Comment & Response] re: Sarkar RR, Parsons JK, Bryant AK, et al.]

Authors
IM Thompson;CM Tangen;B Kramer
Journal / Conference
JAMA Internal Medicine Oct 1;179(10):1440
Year
2019
Research Committee(s)
Cancer Control
PMID
PMID31589258
Study Number(s)
SWOG-9217

Adjuvant Chemotherapy with Standard Regimens versus Capecitabine in Older Women with Early Stage Breast Cancer: 10-year update of Alliance/CALGB trial 49907

Authors
H Muss;M Polley;DA Berry;H Liu;C Cirrincione;M Theodoulou;A Mauer;A Kornblith;A Partridge;LG Dressler;HJ Cohen;H Becker;P Kartcheske;J Wheeler;EA Perez;A Wolff;J Gralow;H Burstein;AA Mahmood;G Magrinat;BA Parker;RD Hart;D Grenier;Arti Hurria;L Norton;C Hudis;E Winer;L Carey
Journal / Conference
Journal of Clinical Oncology Sep 10;37(26):2338-2348. doi: 10.1200/JCO.19.00647. Epub 2019 Jul 24.
Year
2019
Research Committee(s)
Breast
PMID
PMID31339827
PMC
PMC6900836

Prevalence of drug-drug interactions in oncology patients enrolled in two completed SWOG clinical trials

Authors
L Marcath;C Finley;S-F Wong;D Hertz
Journal / Conference
American College of Clinical Pharmacology (9/15-17/2019, Chicago, IL), poster
Year
2019
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S0528, S0711

Validation of the DNA Damage Immune Response (DDIR) Signature in Triple-Negative Breast Cancer (TNBC) Patients from the SWOG 9313c Trial

Authors
P Sharma;W Barlow;A Godwin;E Parkes;L Knight;SM Walker;RD Kennedy;D Harkin;G Logan;CJ Steele;S Lambe;S Badve;Y Gokmen-Polar;H Pathak;K Isakova;HM Linden;P Porter;L Pusztai;AM Thompson;D Tripathy;G Hortobagyi;D Hayes
Journal / Conference
Journal of Clinical Oncology Dec 20;37(36):3484-3492; Oct 28[Online ahead of print]
Year
2019
Research Committee(s)
Breast
PMID
PMID31657982
PMC
PMC7194448
Study Number(s)
SWOG-9313

Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the NCCTG N9831 (Alliance) Study

Authors
C Thorpe;C Vargas;A Dueck;K Tenner;E Perez;ES Hwang;M Halyard;T Pisansky;S Martino;N Davidson;B Pockaj
Journal / Conference
ASTRO Annual Meeting (9/15-18/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Breast
Study Number(s)
N9831

Fractures in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG S0307 trial (ClinicalTrials.gov Identifier: NCT00127205)

Authors
R Yung;J Miao;AHG Paterson;M Clemons;E Dees;JN Ingle;CI Falkson;W Barlow;G Hortobagyi;J Gralow
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 10-14, 2019, San Antonio, TX), P2-18-03, poster
Year
2019
Research Committee(s)
Breast
Study Number(s)
S0307

Baseline Factors Associated with Aromatase Inhibitor Adherence Failure among Women in Enrolled in a Randomized Trial of Text-Messaging: SWOG S1105

Authors
DL Hershman;JM Unger;A Moseley;G Clarke Hillyer;K Arnold;JR Gralow;NL Henry;S Ramsey;A Neugut
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 10-14, 2019, San Antonio, TX), poster, spotlight session
Year
2019
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

Increasing lengths of first complete remission with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data

Authors
M Othus;G Garcia-Manero;JE Godwin;JK Weick;F Appelbaum;H Erba;E Estey
Journal / Conference
Blood (2019) 134 (Supplement_1): 291, abst 613 (American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), oral
Year
2019
Research Committee(s)
Leukemia
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333

Alliance A041701 - A randomized phase 2/3 study of conventional chemotherapy +/- uproleselan (GMI-1271) in older adults with acute myeloid leukemia receiving intensive induction chemotherapy

Authors
G Uy;V Yin;H Klepin;S Dinner;A Jaslowski;SA Strickland;J Liesveld;J Byrd;RM Stone
Journal / Conference
Blood (2019) 134 (Supplement_1): 1366. American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), TIPS, poster
Year
2019
Research Committee(s)
Leukemia